Calyxt Weighs Merger Amid Continued Losses | Twin Cities Business
The company, which has operated at a loss for four years, listed multiple possible business pivots, including the possibility of a merger.
Stay updated with breaking news from Michaela Carr. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The company, which has operated at a loss for four years, listed multiple possible business pivots, including the possibility of a merger.
/PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, today announced that Michael A. Carr, President and Chief Executive...
Evaluated nine new customer demand-driven plant-based chemistries in the quarter, bringing cumulative chemistries evaluated for development to 95, of these 31...
/PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, today announced that Michael A. Carr, Chief Executive Officer, and Bill...
/PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, will host a conference call and webcast on Thursday, August 4, 2022, at...